Latest News

Venture capital firms with €6 billion in funds target Irish medtech sector.

Dublin, Ireland, March 28, 2014.  Over 30 venture capital firms with more than €6 billion in funds under management are meeting in Dublin on April 8 for three days to explore opportunities to invest in the burgeoning Irish medical technology sector. Leading international names such as Omnes Capital, Abingworth and Sofinnova will be among the big players eyeing the sector...


New Screening Tool for Osteoporosis.

10 March 2014   Seroba Kernel’s investee company, Crescent Diagnostics Ltd (“Crescent”), has launched Osentia™, a new convenient screening test which identifies those at risk of fragility fracture by analysing finger or toe nail clippings. Launching in the UK, Osentia™ is available online and will shortly be available direct from pharmacies. The test enables...


Covagen Adds Baxter Ventures as Investor.

ZURICH-SCHLIEREN, Switzerland, Feb 19, 2014 – Seroba Kernel investee company, Covagen, today announced it has added Baxter Ventures as an investor in its Series B financing round raising the total to CHF 44.9 million. The Series B includes an option for all existing investors to invest an additional CHF 14 million in the future, potentially increasing the total amount of this...


< back to home page